CLOV | Clover Health Investments, Corp. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	3.32 - 3.40
52 Week Range	0.6250 - 4.87
Beta	2.26
Implied Volatility	279.89%
IV Rank	11.49%
Day's Volume	3,535,443
Average Volume	5,724,391
Shares Outstanding	510,906,717
Market Cap	1,737,082,838
Sector	Healthcare
Industry	Medical - Healthcare Plans
IPO Date	2020-06-12

Valuation
Profitability
Growth
Health
P/E Ratio	-37.78
Forward P/E Ratio	-3.92
EPS	-0.09
1YR Price Target	3.50
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	552
Country	USA
Website	CLOV

Clover Health Investments Corp is a healthcare technology company. It uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients.

CLOV's peers: ALHC, WISH, SKLZ, BB, FUBO, SNDL, CRSR, OSCR, PSFE

*Chart delayed

Analyzing fundamentals for CLOV we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is frighteningly weak. For more detailed analysis please see CLOV Fundamentals page.

Watching at CLOV technicals we can see that long-term trend is bullish, while middle-term trend is bearish, as well as bearish short-term trend. More technicals details can be found on CLOV Technicals page.